Apoptotic conversion: Evidence for exchange of genetic information between prostate cancer cells mediated by apoptosis

Cancer Research

Volumn 59, Issue 21, 1999, Pages 5461-5463

  De La Taille, Alexandre ^b,c   Chen, Min Wei ^b   Burchardt, Martin ^b   Chopin, Dominique K ^c   Buttyan, Ralph ^a,b  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

^b Coll Phys Surgs of Columbia Univ ^*  (United States)

^c HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; DNA DETERMINATION; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; HUMAN CELL; MALE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROSTATE CANCER;

ANTI-BACTERIAL AGENTS; APOPTOSIS; BLOTTING, SOUTHERN; CINNAMATES; CLONE CELLS; COCULTURE TECHNIQUES; DNA, COMPLEMENTARY; DRUG RESISTANCE, MICROBIAL; HUMANS; HYGROMYCIN B; MALE; NEOMYCIN; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0033230506     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Bratton, D. L., Fadok, V. A., Richter, D. A., Kailey, J. M., Guthrie, L. A., and Henson, P. M. Appearance of phosphatidylserine on apoptotic cells requires calcium-mediated nonspecific flip-flop and is enhanced by loss of the aminophospholipid translocase. J. Biol. Chem., 272: 26159-26165, 1997.
2. Emote, K., Toyama-Sorimachi, N., Karasuyama, H., Inoue, K., and Umeda, M. Exposure of phosphatidylethanolamine on the surface of apoptotic cells. Exp. Cell Res., 232: 430-434, 1997.
3. Naito, M., Nagashima, K., Mashima, T., and Tsuruo, T. Phosphatidylserine externalization is a downstream event of interleukin-1β-converting enzyme family protease activation during apoptosis. Blood, 89: 2060-2066, 1997.
4. Adayev, T., Estephan, R., Meserole, S., Mazza, B., Yurkow, E. J., and Banerjee, P. Externalization of phosphatidylserine may not be an early signal of apoptosis in neuronal cells, but only the phosphatidylserine-displaying apoptotic cells are phagocytosed by microglia. J. Neurochem., 71: 1854-1864, 1998.
5. Chan, A., Reiter, R., Wiese, S., Fertig, G., and Gold, R. Plasma membrane phospholipid asymmetry precedes DNA fragmentation in different apoptotic cell models. Histochem. Cell Biol., 110: 553-558, 1998.
6. Stuart, M. C., Damoiseaux, J. G., Frederik, P. M., Arends, J. W., and Reutelingsperger, C. P. Surface exposure of phosphatidylserine during apoptosis of rat thymocytes precedes nuclear changes. Eur. J. Cell Biol., 76: 77-83, 1998.
7. van Engeland, M., Nieland, L. J., Ramaekers, F. C., Schutte, B., and Reutelingsperger, C. P. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry, 31: 1-9, 1998.
8. Bevers, E. M., Comfurius, P., Dekkers, D. W., Harmsma, M., and Zwaal, R. F. Regulatory mechanisms of transmembrane phospholipid distributions and pathophysiological implications of transbilayer lipid scrambling. Lupus, 7(Suppl. 2): S126-S131, 1998.
9. Dini, L., Ruzittu, M. T., and Falasca, L. Recognition and phagocytosis of apoptotic cells. Scanning Microsc., 10: 239-251, 1996.
10. Shiratsuchi, A., Osada, S., Kanazawa, S., and Nakanishi, Y. Essential role of phosphatidylserine externalization in apoptosing cell phagocytosis by macrophages. Biochem. Biophys. Res. Commun., 246: 549-555, 1998.
11. Franc, N. C., Heitzler, P., Ezekowitz, R. A., and White, K. Requirement for croquemort in phagocytosis of apoptotic cells in Drosophila. Science (Washington DC), 284: 1991-1994, 1999.
12. Fadok, V. A., and Henson, P. M. Apoptosis: getting rid of the bodies. Curr. Biol., 8: R693-R695, 1998.
13. Ren, Y., and Savill, J. Apoptosis: the importance of being eaten. Cell Death Differ., 5: 563-568, 1998.
14. Savill, J. Apoptosis. Phagocytic docking without shocking. Nature (Lond.), 392: 442-443, 1998.
15. Raffo, A. J., Perlman, H., Chen, M. W., Day, M. L., Streitman, J. S., and Buttyan, R. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res., 55: 4438-4445, 1995.
16. Aihara, M., Truong, L. D., Dunn, J. K., Wheeler, T. M., Scardino, P. T., and Thompson T. C. Frequency of apoptotic bodies positively correlates with Gleason grade in prostate cancer. Hum. Pathol., 25: 797-801, 1994.
17. Aihara, M., Scardino, P. T., Truong, L. D., Wheeler, T. M., Goad, J. R., Yang, G., and Thompson, T. C. The frequency of apoptosis correlates with the prognosis of Gleason grade 3 adenocarcinoma of the prostate. Cancer (Phila.), 75: 522-529, 1995.
18. Ruijter, E., van de Kaa, C., Aalders, T., Ruiter, D., Miller, G., Debruyne, F., and Schalken, J. Heterogeneous expression of E-cadherin and p53 in prostate cancer: clinical implications. BIOMED-II Markers for Prostate Cancer Study Group. Mod. Pathol., 11: 276-281, 1998.
19. Gao, J., Tombal, B., and Isaacs, J. T. Rapid in situ hybridization technique for detecting malignant mouse cell contamination in human xenograft tissue from nude mice and in vitro cultures from such xenografts. Prostate, 39: 67-70, 1999.